Find Paid Clinical Trials in Spain

Paid Clinical Trials and Focus Groups by Location

All Locations ... Spain

Visual and Economic Profits of ReSTOR® Multifocal Intraocular Lenses (IOL) on Public Health Patients in Spain

Condition: Presbyopia
Intervention: Procedure: Cataract surgery
Sponsor: University of Barcelona
Not yet recruiting - verified February 2010
Study of Pemetrexed Disodium Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous Cell Lung Cancer: a Pharmacogenomic Trial

Condition: Non-Small-Cell-Lung Cancer
Intervention: Drug: Pemetrexed/Cisplatin
Sponsor: Spanish Lung Cancer Group
Recruiting - verified March 2010
SEGUDIAB Study: Evaluation of Safety in the Diabetic Patients

Condition: Diabetes Mellitus
Intervention: Behavioral: Educational program
Sponsors: Jordi Gol i Gurina Foundation; Departament de Salut Generalitat de Catalunya; Fundación Avedis Donabedian
Active, not recruiting - verified March 2010
Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO)

Condition: Ischemic Stroke
Intervention: Procedure: Mechanical Thrombectomy
Sponsor: Concentric Medical
Recruiting - verified March 2010
Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse

Condition: Multiple Myeloma
Interventions: Drug: zoledronic acid; Other: No treatment control
Sponsors: PETHEMA Foundation; Dynamic Solutions S.L. (Contract Research Organization); Novartis Farmacéutica S.A
Not yet recruiting - verified March 2010
European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial

Condition: ST Segment Elevation Acute Coronary Syndrome
Interventions: Drug: Bivalirudin; Drug: Heparin
Sponsor: The Medicines Company
Recruiting - verified March 2010
Reduction of the Metabolic Syndrome in Navarra-Spain

Conditions: Metabolic Syndrome; Obesity; Diabetes; Cardiovascular Disease
Interventions: Behavioral: Crononutrition; Behavioral: American Heart Association
Sponsors: Instituto Cientifico y Tecnologico de Navarra, Universidad de Navarra; Hospital of Navarra
Recruiting - verified March 2010
Stress Hyperglycemia. Potential Role of Incretin Analogs

Conditions: Hyperglycemia; Critical Illness
Intervention:
Sponsors: Hospital Universitari Son Dureta; Fundació Mateu Orfila
Recruiting - verified March 2010
Diagnosis of Intestinal Motility by Image Analysis Using Capsule Endoscopy

Condition: Intestinal Abnormalities
Intervention: Device: PillCam SB2
Sponsor: Given Imaging Ltd.
Recruiting - verified March 2010
Effects of a Program of Physical Exercise and Electrotherapy on Muscle Strength in Subjects of the Fourth Age

Conditions: Geriatric Assessment; Muscle Strength; Postural Balance; Body Mass Index
Interventions: Other: No intervention; Other: Strong progressive strengthening exercises of lower limbs; Other: Electrotherapy; Other: Electrotherapy+weights
Sponsor: Cardenal Herrera University
Recruiting - verified February 2010
Efficacy and Safety of Intravenous Iron Sucrose in Patients With Hip Fracture to Prevent Perioperative Anemia

Conditions: Hip Fracture; Surgical Intervention
Intervention: Drug: Iron sucrose
Sponsor: Hospital Clinic of Barcelona
Not yet recruiting - verified January 2010
PeriOperative ISchemic Evaluation-2 Trial

Condition: Cardiovascular Disease
Interventions: Drug: Active Clonidine; Drug: Placebo Clonidine; Drug: Active ASA; Drug: Placebo ASA
Sponsor: Hamilton Health Sciences
Not yet recruiting - verified March 2010
ARIpiprazole in Anorexia NErvosa

Condition: Anorexia Nervosa
Interventions: Drug: aripiprazole; Drug: placebo
Sponsor: Hospital Clinic of Barcelona
Not yet recruiting - verified March 2010
Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure

Condition: Multiple Myeloma
Intervention: Drug: velcade
Sponsor: PETHEMA Foundation
Not yet recruiting - verified March 2010
Hospitalization or Ambulatory Treatment of Acute Diverticulitis

Condition: Diverticulitis
Intervention: Other: Ambulatory versus hospitalisation
Sponsor: Hospital Universitari de Bellvitge
Recruiting - verified February 2009
MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Condition: Metastatic Colorectal Cancer
Interventions: Drug: Mek Inhibitor MSC1936369B; Drug: Mek Inhibitor MSC1936369B; Drug: Placebo; Drug: FOLFIRI
Sponsor: EMD Serono
Recruiting - verified March 2010
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Conditions: Allergic Rhinoconjunctivitis; Chronic Urticaria
Intervention: Drug: Bilastine
Sponsor: Faes Farma, S.A.
Recruiting - verified March 2010
Global Performance Evaluation of the AMS CONTINUUM™ Device

Condition: Prostate Cancer
Intervention: Device: CONTINUUM™
Sponsor: American Medical Systems
Recruiting - verified March 2010
Pharmacokinetics in Morbid Obesity After Bariatric Surgery

Conditions: Morbid Obesity; Overweight; Normal Weight
Intervention: Procedure: Surgery
Sponsors: Fundacion IMIM; Parc de Salut Mar
Recruiting - verified October 2009
A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

Conditions: Infertility; Ovulation Induction
Interventions: Drug: Lutropin alfa for injection (r-hLH) + r-hFSH; Drug: r-hFSH preparation
Sponsor: Merck KGaA
Recruiting - verified March 2010
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia

Conditions: Diabetes; Limb Ischemia
Interventions: Other: Autologous mesenchymal stem cells from adipose tissue.; Other: Autologous mesenchymal stem cells from adipose tissue.; Other: Autologous mesenchymal stem cells from adipose tissue.
Sponsors: Fundacion Progreso y Salud, Spain; Carlos III Health Institute
Recruiting - verified January 2010
Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis

Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Active, not recruiting - verified February 2010
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

Condition: Non Small Cell Lung Cancer
Intervention:
Sponsor: AstraZeneca
Not yet recruiting - verified March 2010
Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation

Condition: Anaemia
Interventions: Drug: IV trivalent saccharose hydroxide ferrous; Drug: Oral ferrous fumarate; Drug: Oral and intravenous Placebo
Sponsor: Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Completed - verified May 2007
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer

Condition: Ovarian Cancer
Interventions: Drug: olaparib; Drug: paclitaxel; Drug: carboplatin
Sponsor: AstraZeneca
Recruiting - verified March 2010
Efficacy of a Disease Management Program in Very Old Patients With Heart Failure

Conditions: Heart Failure; Comorbidity; Case-manager
Interventions: Other: Disease management program; Behavioral: Usual care
Sponsors: Hospital de Meixoeiro; Funadación Biomedica del Complejo Hospitalario Universitario de Vigo; Universidad Autonoma de Madrid; Fondo de Investigacion Sanitaria
Recruiting - verified January 2010
Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients - PORTREAT

Condition: Prostatic Neoplasms
Intervention:
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age

Conditions: Infertility; Ovulation Induction
Intervention: Drug: Lutropin alfa
Sponsor: Merck KGaA
Recruiting - verified March 2010
Colorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

Condition: Colorectal Cancer
Interventions: Procedure: Immunochemical fecal occult blood test And colonoscopy if test is positive; Procedure: Colonoscopy with sedation
Sponsor: Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Recruiting - verified September 2008
Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease

Condition: Severe Respiratory Syncytial Virus Infection
Intervention:
Sponsor: Abbott
Completed - verified February 2010
CoreValve Advance International Post Market Study

Condition: Severe Aortic Valve Stenosis
Intervention: Device: Medtronic CoreValve System
Sponsor: Medtronic Bakken Research Center
Recruiting - verified March 2010
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-2)

Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
B-cryptoxanthin and Phytosterols on Bone Remodeling and Cardiovascular Risk Factors

Condition: Post-menopausal
Intervention: Dietary Supplement: b-cryptoxanthin and phytosterols
Sponsor: Puerta de Hierro University Hospital
Active, not recruiting - verified February 2010
Efficacy of Electrotherapy in Subacromial Impingement Syndrome

Condition: Shoulder Impingement Syndrome
Interventions: Procedure: Short-wave therapy; Procedure: Ultrasonic therapy; Procedure: Inactive electrotherapy
Sponsors: Fundacio Espai Salut; Corporación Fisiogestión S.A.; Hospital Clinic of Barcelona; Agència d'Avaluació de Tecnologia i Recerca Mèdiques (AATRM)
Recruiting - verified February 2010
Stroke Treatment With Acute Reperfusion and Simvastatin

Condition: Stroke, Acute
Intervention: Drug: Simvastatin
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Recruiting - verified February 2010
Sleep Apnea Syndrome and Community Acquired Pneumonia

Conditions: Sleep Apnea Syndrome; Polygraphy; Community Acquired Pneumonia; Infections
Intervention: Device: abbreviated polysomnography
Sponsor: Hospital Universitario San Juan de Alicante
Completed - verified February 2006
Treatment Interruption of Natalizumab

Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: natalizumab; Drug: interferon beta 1-a; Drug: methylprednisolone; Other: IV placebo; Drug: glatiramer acetate
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010

Find Paid Clinical Trials in Spain - Clinical Trials

Find Paid Clinical Trials in Spain

Paid Clinical Trials and Focus Groups by Location

Main Menu

Find Clinical Trials

Clinical Trial Locations

Clinical Trial Categories

Patient Recruiting...

Paid Clinical Trials